4//SEC Filing
Protalix BioTherapeutics, Inc. 4
Accession 0001144204-14-064729
$PLXCIK 0001006281operating
Filed
Nov 2, 7:00 PM ET
Accepted
Nov 3, 5:06 PM ET
Size
5.8 KB
Accession
0001144204-14-064729
Insider Transaction Report
Form 4
Manor Moshe
President & CEO
Transactions
- Award
Stock Options (Right to Buy)
2014-09-29+900,000→ 900,000 totalExercise: $2.37Exp: 2024-09-29→ Common Stock (900,000 underlying)
Footnotes (1)
- [F1]The options vest over a four-year period in 16 equal increments, subject to certain terms and conditions. Vesting of the options will be accelerated in full upon a Corporate Transaction or a Change in Control, as those terms are defined in the issuer's 2006 Stock Incentive Plan, as amended.
Documents
Issuer
Protalix BioTherapeutics, Inc.
CIK 0001006281
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001006281
Filing Metadata
- Form type
- 4
- Filed
- Nov 2, 7:00 PM ET
- Accepted
- Nov 3, 5:06 PM ET
- Size
- 5.8 KB